Literature DB >> 17326126

Clinicopathologic features of poorly differentiated hepatocellular carcinoma.

Koichi Oishi1, Toshiyuki Itamoto, Hironobu Amano, Saburo Fukuda, Hideki Ohdan, Hirotaka Tashiro, Fumio Shimamoto, Toshimasa Asahara.   

Abstract

BACKGROUND AND OBJECTIVES: Clinicopathologic features of poorly differentiated hepatocellular carcinoma (HCC) have not been elucidated. The purpose of this study was to clarify the characteristics of poorly differentiated HCC in hepatectomized patients.
METHODS: From 1986 to 2001, 354 HCC patients underwent curative hepatectomy in our institution and were prospectively followed. Histological examinations revealed 43 well-differentiated HCC tumors, 273 moderately differentiated HCC tumors, and 38 poorly differentiated HCC tumors. Clinicopathologic factors and outcomes after hepatectomy were compared statistically.
RESULTS: Only serum alpha-fetoprotein level was significantly different in the poorly differentiated HCC group from that in the moderately differentiated HCC group preoperatively (P=0.0001). Although there were no significant differences between overall survival rates or between disease-free survival rates in the three groups, distant metastasis within 2 years after hepatectomy occurred more frequently in the poorly differentiated HCC group (21%) than in the well-differentiated HCC group (2%) (P=0.011) or moderately differentiated HCC group (8%) (P=0.018). Distant metastasis occurred in about 40% of patients in the poorly differentiated HCC group with tumor size greater than 3 cm.
CONCLUSIONS: Poorly differentiated HCC tumors larger than 3 cm are already of advanced stage representing distant metastasis in the early period after hepatectomy. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326126     DOI: 10.1002/jso.20661

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  34 in total

1.  Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.

Authors:  Chansik An; Mi-Suk Park; Hyae-Min Jeon; Yeo-Eun Kim; Woo-Suk Chung; Yong Eun Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2012-03-22       Impact factor: 5.315

2.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

3.  Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.

Authors:  Mohamed Abd El-Fattah
Journal:  Indian J Gastroenterol       Date:  2017-02-14

4.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

5.  AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.

Authors:  Kentaroh Yamamoto; Hiroshi Imamura; Yutaka Matsuyama; Yukio Kume; Hitoshi Ikeda; Gary L Norman; Zakera Shums; Taku Aoki; Kiyoshi Hasegawa; Yoshifumi Beck; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  J Gastroenterol       Date:  2010-07-13       Impact factor: 7.527

Review 6.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

7.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Authors:  Shotaro Enomoto; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2011-01-09       Impact factor: 6.047

8.  Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.

Authors:  Yusuke Ogihara; Yoshio Kitazume; Yoshihiro Iwasa; Shinichi Taura; Yoshiro Himeno; Tomo Kimura; Seishi Sawano; Shigehiko Terada; Minoru Tanabe; Yukihisa Saida; Ukihide Tateishi
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

9.  Prediction of long-term survival rates in patients undergoing curative resection for solitary hepatocellular carcinoma.

Authors:  Yi Cao; Zhelong Jiang; Shaohu Wang; Haoyang Zhang; Yi Jiang; Lizhi Lv
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

10.  Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma.

Authors:  Keh M Ng; Tristan D Yan; Deborah Black; Francis C K Chu; David L Morris
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.